Living Cell Technologies Ltd. released its earnings results on Aug 30, 2024. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.

Q: Is Living Cell Technologies Ltd. overvalued?

According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Living Cell Technologies Ltd. have?

Living Cell Technologies Ltd. has 1,687,394,800 shares outstanding.

Q: What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?

Living Cell Technologies Ltd. reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -9.091%.

Compare

1 Followers

1AI Stock Chart & Stats

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.01

Previous CloseN/A

Volume31.97M

Average Volume (3M)572.76K

Market Cap

AU$10.12M

Enterprise ValueAU$13.77M

Total Cash (Recent Filing)7.53M

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.22

Next Earnings

Aug 28, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,687,394,800

10 Day Avg. Volume1,041,854

30 Day Avg. Volume572,756

Standard Deviation0.23

R-Squared0.14

Alpha-0.00105

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)3066.44

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

---

Living Cell Technologies Ltd. News

PremiumCompany Announcements

Algorae Pharmaceuticals Advances Drug Development and Strengthens Financial Position

24d ago

PremiumCompany Announcements

Algorae Pharmaceuticals’ AI-168 Shows Promising Results

3M ago

PremiumCompany Announcements

Algorae Pharmaceuticals Strengthens Board with Industry Expert

3M ago

PremiumCompany Announcements

Algorae Pharmaceuticals Expands Pipeline with AI-Driven Targets

3M ago

PremiumCompany Announcements

Algorae Pharmaceuticals Plans Major Securities Issuance

3M ago

PremiumCompany Announcements

Algorae Pharmaceuticals Streamlines Operations with OTCQB Exit

3M ago

PremiumCompany Announcements

Living Cell Technologies Announces Director’s Interest Change

4M ago

PremiumCompany Announcements

Algorae Pharmaceuticals Plans Major Securities Issuance

4M ago

See All AU:1AI News

---

Financials

Quarterly

Income Statement >

1AI FAQ

What was Living Cell Technologies Ltd.’s price range in the past 12 months?

Living Cell Technologies Ltd. lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.

What is Living Cell Technologies Ltd.’s market cap?

Living Cell Technologies Ltd.’s market cap is AU$10.12M.

When is Living Cell Technologies Ltd.’s upcoming earnings report date?

Living Cell Technologies Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 187 days.

How were Living Cell Technologies Ltd.’s earnings last quarter?

Living Cell Technologies Ltd. released its earnings results on Aug 30, 2024. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.

Is Living Cell Technologies Ltd. overvalued?

According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Living Cell Technologies Ltd. pay dividends?

Living Cell Technologies Ltd. does not currently pay dividends.

What is Living Cell Technologies Ltd.’s EPS estimate?

Living Cell Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Living Cell Technologies Ltd. have?

Living Cell Technologies Ltd. has 1,687,394,800 shares outstanding.

What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?

Living Cell Technologies Ltd. reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -9.091%.

Which hedge fund is a major shareholder of Living Cell Technologies Ltd.?

Currently, no hedge funds are holding shares in AU:1AI

---

Living Cell Technologies Ltd. Stock Smart Score

Neutral

Blogger Sentiment

Bullish

AU:1AI Sentiment 70%
Sector Average 70%

News Sentiment

Neutral

Bullish news 50%
Bearish news 100%

Fundamentals

Return on Equity

-60.70%

Trailing 12-Months

Asset Growth

-23.95%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Living Cell Technologies Ltd.

Living Cell Technologies Ltd. is a biotechnology company. It engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Auckland, New Zealand.

---

Similar Stocks

MEOBF

Mesoblast Limited

―

OCC

Orthocell Ltd

―

PYC

PYC Therapeutics Limited

―

RCE